Variation at the NFATC2 Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment With Ramipril and Rosiglitazone Medication (DREAM) Study
Diabetes Care - United States
doi 10.2337/dc10-0452
Full Text
Open PDFAbstract
Available in full text
Date
July 13, 2010
Authors
Publisher
American Diabetes Association